COPD用治療薬の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21JNE3677)
◆英語タイトル:Global COPD Medication Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE3677
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年6月(※2024年版があります。お問い合わせください。)
◆ページ数:97
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、COPD用治療薬の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(短時間作用型気管支拡張薬、コルチコステロイド、メチルキサンチン、長時間作用型気管支拡張薬、併用薬)、用途別市場規模(病院、診療所、薬局、オンライン薬局)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・COPD用治療薬の市場動向
・企業の競争状況、市場シェア
・COPD用治療薬の種類別市場規模(短時間作用型気管支拡張薬、コルチコステロイド、メチルキサンチン、長時間作用型気管支拡張薬、併用薬)
・COPD用治療薬の用途別市場規模(病院、診療所、薬局、オンライン薬局)
・COPD用治療薬の北米市場規模2016-2027(アメリカ、カナダ)
・COPD用治療薬の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・COPD用治療薬のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・COPD用治療薬の中南米市場規模2016-2027(メキシコ、ブラジル)
・COPD用治療薬の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Roche、Novartis、GSK、Teva、AstraZeneca、Boehringer Ingelheim、Nephron Pharmaceuticals)
・結論
【レポートの概要】

Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory lung disease that causes obstructed airflow from the lungs. Symptoms include breathing difficulty, cough, mucus (sputum) production and wheezing. It’s typically caused by long-term exposure to irritating gases or particulate matter, most often from cigarette smoke.

Market Analysis and Insights: Global COPD Medication Market
The global COPD Medication market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global COPD Medication market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global COPD Medication market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global COPD Medication market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global COPD Medication market.

Global COPD Medication Scope and Market Size
COPD Medication market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global COPD Medication market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Short-Acting Bronchodilator
Corticosteroids
Methylxanthines
Long-Acting Bronchodilators
Combination Drugs

Segment by Application
Hospital
Clinic
Pharmacy
Online Pharmacy

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Roche
Novartis
GSK
Teva
AstraZeneca
Boehringer Ingelheim
Nephron Pharmaceuticals

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global COPD Medication Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Short-Acting Bronchodilator
1.2.3 Corticosteroids
1.2.4 Methylxanthines
1.2.5 Long-Acting Bronchodilators
1.2.6 Combination Drugs
1.3 Market by Application
1.3.1 Global COPD Medication Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacy
1.3.5 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global COPD Medication Market Perspective (2016-2027)
2.2 COPD Medication Growth Trends by Regions
2.2.1 COPD Medication Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 COPD Medication Historic Market Share by Regions (2016-2021)
2.2.3 COPD Medication Forecasted Market Size by Regions (2022-2027)
2.3 COPD Medication Industry Dynamic
2.3.1 COPD Medication Market Trends
2.3.2 COPD Medication Market Drivers
2.3.3 COPD Medication Market Challenges
2.3.4 COPD Medication Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top COPD Medication Players by Revenue
3.1.1 Global Top COPD Medication Players by Revenue (2016-2021)
3.1.2 Global COPD Medication Revenue Market Share by Players (2016-2021)
3.2 Global COPD Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by COPD Medication Revenue
3.4 Global COPD Medication Market Concentration Ratio
3.4.1 Global COPD Medication Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by COPD Medication Revenue in 2020
3.5 COPD Medication Key Players Head office and Area Served
3.6 Key Players COPD Medication Product Solution and Service
3.7 Date of Enter into COPD Medication Market
3.8 Mergers & Acquisitions, Expansion Plans

4 COPD Medication Breakdown Data by Type
4.1 Global COPD Medication Historic Market Size by Type (2016-2021)
4.2 Global COPD Medication Forecasted Market Size by Type (2022-2027)

5 COPD Medication Breakdown Data by Application
5.1 Global COPD Medication Historic Market Size by Application (2016-2021)
5.2 Global COPD Medication Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America COPD Medication Market Size (2016-2027)
6.2 North America COPD Medication Market Size by Type
6.2.1 North America COPD Medication Market Size by Type (2016-2021)
6.2.2 North America COPD Medication Market Size by Type (2022-2027)
6.2.3 North America COPD Medication Market Size by Type (2016-2027)
6.3 North America COPD Medication Market Size by Application
6.3.1 North America COPD Medication Market Size by Application (2016-2021)
6.3.2 North America COPD Medication Market Size by Application (2022-2027)
6.3.3 North America COPD Medication Market Size by Application (2016-2027)
6.4 North America COPD Medication Market Size by Country
6.4.1 North America COPD Medication Market Size by Country (2016-2021)
6.4.2 North America COPD Medication Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe COPD Medication Market Size (2016-2027)
7.2 Europe COPD Medication Market Size by Type
7.2.1 Europe COPD Medication Market Size by Type (2016-2021)
7.2.2 Europe COPD Medication Market Size by Type (2022-2027)
7.2.3 Europe COPD Medication Market Size by Type (2016-2027)
7.3 Europe COPD Medication Market Size by Application
7.3.1 Europe COPD Medication Market Size by Application (2016-2021)
7.3.2 Europe COPD Medication Market Size by Application (2022-2027)
7.3.3 Europe COPD Medication Market Size by Application (2016-2027)
7.4 Europe COPD Medication Market Size by Country
7.4.1 Europe COPD Medication Market Size by Country (2016-2021)
7.4.2 Europe COPD Medication Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific COPD Medication Market Size (2016-2027)
8.2 Asia-Pacific COPD Medication Market Size by Type
8.2.1 Asia-Pacific COPD Medication Market Size by Type (2016-2021)
8.2.2 Asia-Pacific COPD Medication Market Size by Type (2022-2027)
8.2.3 Asia-Pacific COPD Medication Market Size by Type (2016-2027)
8.3 Asia-Pacific COPD Medication Market Size by Application
8.3.1 Asia-Pacific COPD Medication Market Size by Application (2016-2021)
8.3.2 Asia-Pacific COPD Medication Market Size by Application (2022-2027)
8.3.3 Asia-Pacific COPD Medication Market Size by Application (2016-2027)
8.4 Asia-Pacific COPD Medication Market Size by Region
8.4.1 Asia-Pacific COPD Medication Market Size by Region (2016-2021)
8.4.2 Asia-Pacific COPD Medication Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America COPD Medication Market Size (2016-2027)
9.2 Latin America COPD Medication Market Size by Type
9.2.1 Latin America COPD Medication Market Size by Type (2016-2021)
9.2.2 Latin America COPD Medication Market Size by Type (2022-2027)
9.2.3 Latin America COPD Medication Market Size by Type (2016-2027)
9.3 Latin America COPD Medication Market Size by Application
9.3.1 Latin America COPD Medication Market Size by Application (2016-2021)
9.3.2 Latin America COPD Medication Market Size by Application (2022-2027)
9.3.3 Latin America COPD Medication Market Size by Application (2016-2027)
9.4 Latin America COPD Medication Market Size by Country
9.4.1 Latin America COPD Medication Market Size by Country (2016-2021)
9.4.2 Latin America COPD Medication Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa COPD Medication Market Size (2016-2027)
10.2 Middle East & Africa COPD Medication Market Size by Type
10.2.1 Middle East & Africa COPD Medication Market Size by Type (2016-2021)
10.2.2 Middle East & Africa COPD Medication Market Size by Type (2022-2027)
10.2.3 Middle East & Africa COPD Medication Market Size by Type (2016-2027)
10.3 Middle East & Africa COPD Medication Market Size by Application
10.3.1 Middle East & Africa COPD Medication Market Size by Application (2016-2021)
10.3.2 Middle East & Africa COPD Medication Market Size by Application (2022-2027)
10.3.3 Middle East & Africa COPD Medication Market Size by Application (2016-2027)
10.4 Middle East & Africa COPD Medication Market Size by Country
10.4.1 Middle East & Africa COPD Medication Market Size by Country (2016-2021)
10.4.2 Middle East & Africa COPD Medication Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche COPD Medication Introduction
11.1.4 Roche Revenue in COPD Medication Business (2016-2021)
11.1.5 Roche Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis COPD Medication Introduction
11.2.4 Novartis Revenue in COPD Medication Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 GSK
11.3.1 GSK Company Details
11.3.2 GSK Business Overview
11.3.3 GSK COPD Medication Introduction
11.3.4 GSK Revenue in COPD Medication Business (2016-2021)
11.3.5 GSK Recent Development
11.4 Teva
11.4.1 Teva Company Details
11.4.2 Teva Business Overview
11.4.3 Teva COPD Medication Introduction
11.4.4 Teva Revenue in COPD Medication Business (2016-2021)
11.4.5 Teva Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Details
11.5.2 AstraZeneca Business Overview
11.5.3 AstraZeneca COPD Medication Introduction
11.5.4 AstraZeneca Revenue in COPD Medication Business (2016-2021)
11.5.5 AstraZeneca Recent Development
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Company Details
11.6.2 Boehringer Ingelheim Business Overview
11.6.3 Boehringer Ingelheim COPD Medication Introduction
11.6.4 Boehringer Ingelheim Revenue in COPD Medication Business (2016-2021)
11.6.5 Boehringer Ingelheim Recent Development
11.7 Nephron Pharmaceuticals
11.7.1 Nephron Pharmaceuticals Company Details
11.7.2 Nephron Pharmaceuticals Business Overview
11.7.3 Nephron Pharmaceuticals COPD Medication Introduction
11.7.4 Nephron Pharmaceuticals Revenue in COPD Medication Business (2016-2021)
11.7.5 Nephron Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ COPD用治療薬の世界市場規模・現状・予測2021年-2027年(Global COPD Medication Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。